Feed DXCM
DX

DexCom

DXCM · NASDAQ

$83.03 -1.91% (-$1.62)
1M -7.49%
Market Cap $33.9B
P/E Ratio 33.86x
Div. Yield -
ROE 36.19%

Bulios Fair Price

$44.69

46.2% downside

Trenutna cena

$83.03

Podcenjeno Poštena vrednost Precenjeno

Po podatkih Bulios Fair Price je delnica DXCM trenutno precenjena glede na svojo tržno ceno. Kako deluje?

Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?

Piotroski F-Score Strong
8/9
Valuation
33 /100
Expensive
P/B 12.91x
P/S 6.81x
P/E 33.86x
Growth
96 /100
Growing
Book val. growth 8.81%
FCF growth 52.34%
EPS growth 37.73%
Profitability
98 /100
Strong
FCF margin 28.27%
Op. margin 22.92%
Gross margin 62.47%
Quality
95 /100
Excellent
Asset turnover 0.77x
ROA 15.49%
ROIC 21.60%
Debt
92 /100
Low
Net debt/EBITDA 0.19x
Int. coverage 86.33x
Debt/Equity 0.53x
Stability
76 /100
Stable
Profitable years 6
EPS volatility 27.42%
Beta 1.42x

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o DXCM
Online

O podjetju

DexCom, Inc. (DXCM) is an American healthcare company specializing in the development and production of continuous glucose monitoring (CGM) systems for patients with diabetes. With innovative products like the Dexcom G6, DexCom provides accurate and continuous monitoring of blood sugar levels, allowing patients and healthcare professionals to better manage diabetes and improve quality of life. The company is known for its focus on technological innovations and continuous improvement of its products. DexCom also collaborates with other healthcare companies to integrate its CGM systems into broader healthcare ecosystems. DexCom, Inc. (DXCM) shares could be suitable for investors looking for opportunities in the medical technology sector with a focus on diabetes and innovations in health monitoring.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Medical - Devices

CEO

Jacob Steven Leach

Employees

11,050

Headquarters

San Diego

Prihajajoči dogodki

29 OKT.

Earnings

Upcoming earnings report

46d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.